3,000
Participants
Start Date
April 7, 2025
Primary Completion Date
May 1, 2028
Study Completion Date
December 31, 2028
blood sampling
At baseline, participants will undergo peripheral blood collection using EDTA tubes. A total of 10 mL of venous blood will be collected and processed into plasma and peripheral blood mononuclear cells (PBMCs). Plasma samples will be stored at -80°C, and PBMCs will be cryopreserved in liquid nitrogen. These samples will be used for future biomarker discovery, multi-omics analysis, and studies of biological mechanisms underlying treatment-related toxicities.
RECRUITING
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
ACTIVE_NOT_RECRUITING
Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center, Shenzhen
ACTIVE_NOT_RECRUITING
Shanxi Cancer Hospital, Taiyuan
FangYi
OTHER